Source Natural Foods & Herbal Supplements
Healthcare
531398 BSE
₹109.80
Close ·
- P/E
- 20.18
Close 4 Nov 2026 ₹109.80 −33.85 −23.6% 1Y
Start ₹143.65
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures at the close · EPS basis: Standalone · TTM
- ROCE
- 17.60%
- Debt to Equity
- 0.30
- EPS (TTM)
- ₹5.44
- Book Value
- ₹11.77
- Market Cap
- —
- P/E (TTM)
- 20.18
- P/B
- 9.33
- ROE
- 14.10%
- Dividend Yield
- 0.00%
- EBITDA
- ₹5.90 Cr
- 52W High
- ₹155.90
- 52W Low
- ₹96.55
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
53 Average
Data confidence 100/100
Category scores
- Quality
- 57
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 38
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 96
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 59
- Good
- Solvency, leverage, coverage 9% weight
- Momentum
- 41
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.7% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 7 | 0 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bearish
Bearish
2
Neutral
7
Bullish
0
Overall
Strong Bearish
Bearish
12
Neutral
7
Bullish
0
Moving Averages
Strong Bearish
Bearish
10
Neutral
0
Bullish
0
Key readings
- RSI (14)
- 48.75
- Neutral
- MACD (12,26,9)
- −0.19
- Bearish
- SMA (50)
- 109.94
- Bearish
- SMA (200)
- 117.34
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +20.47% |
|---|---|
| 5Y | +23.12% |
| 3Y | +52.64% |
| 1Y | +56.68% |
| TTM | +63.05% |
Net profit
| 10Y | +22.97% |
|---|---|
| 5Y | +0.18% |
| 3Y | +17.05% |
| 1Y | +17.24% |
| TTM | +12.18% |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Turned negative |
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −0.40 pp |
|---|---|
| 5Y | −8.38 pp |
| 3Y | −9.86 pp |
| 1Y | −1.59 pp |
| TTM | −3.35 pp |
Revenue by year
| Mar 2017 | ₹15.94 Cr |
|---|---|
| Mar 2018 | ₹10.84 Cr |
| Mar 2019 | ₹12.81 Cr |
| Mar 2020 | ₹13.59 Cr |
| Mar 2021 | ₹24.88 Cr |
| Mar 2022 | ₹21.53 Cr |
| Mar 2023 | ₹19.79 Cr |
| Mar 2024 | ₹27.30 Cr |
| Mar 2025 | ₹44.92 Cr |
| Mar 2026 | ₹70.38 Cr |
Net profit by year
| Mar 2017 | ₹1.40 Cr |
|---|---|
| Mar 2018 | ₹0.80 Cr |
| Mar 2019 | ₹1.03 Cr |
| Mar 2020 | ₹1.64 Cr |
| Mar 2021 | ₹3.37 Cr |
| Mar 2022 | ₹2.43 Cr |
| Mar 2023 | ₹2.12 Cr |
| Mar 2024 | ₹1.74 Cr |
| Mar 2025 | ₹2.90 Cr |
| Mar 2026 | ₹3.40 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.58 | 6.89 | 8 | 6.83 | 8.16 | 10.26 | 10.45 | 16.07 | 12.1 | 16.95 | 20.3 | 21.03 | 21.42 |
| Expenses | 5.09 | 6.16 | 6.25 | 5.35 | 7.27 | 8.89 | 8.79 | 14.85 | 10.85 | 15.59 | 18.79 | 18.79 | 20.23 |
| Operating Profit | 0.49 | 0.73 | 1.75 | 1.48 | 0.89 | 1.37 | 1.66 | 1.22 | 1.25 | 1.36 | 1.51 | 2.24 | 1.19 |
| OPM % | 8.78% | 10.6% | 21.88% | 21.67% | 10.91% | 13.35% | 15.89% | 7.59% | 10.33% | 8.02% | 7.44% | 10.65% | 5.56% |
| Other Income | 0.01 | 0 | 0 | −0.05 | 0.01 | 0 | 0.01 | 0.06 | 0.01 | 0 | 0.01 | 0.04 | 0.18 |
| Interest | 0.04 | 0.05 | 0.06 | 0.04 | 0.08 | 0.18 | 0.2 | 0.17 | 0.16 | 0.16 | 0.15 | 0.17 | 0.28 |
| Depreciation | 0.1 | 0.43 | 0.26 | 0.26 | 0.26 | 0.26 | 0.25 | 0.25 | 0.25 | 0.26 | 0.26 | 0.1 | 0.1 |
| PBT | 0.36 | 0.25 | 1.43 | 1.13 | 0.56 | 0.93 | 1.22 | 0.86 | 0.85 | 0.94 | 1.11 | 2.01 | 0.99 |
| Tax % | 25% | 28% | 32.87% | 71.68% | 26.79% | 10.75% | 16.39% | 27.91% | 25.88% | 26.6% | 26.13% | 37.81% | 26.26% |
| Net Profit | 0.27 | 0.19 | 0.96 | 0.32 | 0.42 | 0.84 | 1.02 | 0.63 | 0.63 | 0.7 | 0.82 | 1.24 | 0.74 |
| EPS (₹) | 0.42 | 0.3 | 1.49 | 0.5 | 0.65 | 1.3 | 1.58 | 0.98 | 0.98 | 1.09 | 1.27 | 1.93 | 1.15 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.54 | 10.93 | 15.94 | 10.84 | 12.81 | 13.59 | 24.88 | 21.53 | 19.79 | 27.3 | 44.92 | 70.38 | 79.7 |
| Expenses | 5.83 | 9.97 | 14.12 | 9.43 | 11.22 | 11.2 | 20.71 | 17.68 | 16.18 | 22.83 | 40.44 | 64.48 | 73.4 |
| Operating Profit | 0.71 | 0.96 | 1.82 | 1.41 | 1.59 | 2.39 | 4.17 | 3.85 | 3.61 | 4.47 | 4.48 | 5.9 | 6.3 |
| OPM % | 10.86% | 8.78% | 11.42% | 13.01% | 12.41% | 17.59% | 16.76% | 17.88% | 18.24% | 16.37% | 9.97% | 8.38% | 7.9% |
| Other Income | 0 | 0.01 | 0.01 | 0.01 | 0 | 0.02 | 0.33 | 0.49 | 0.01 | −0.04 | 0.08 | 0.06 | 0.23 |
| Interest | 0.01 | 0.01 | 0.07 | 0.24 | 0.2 | 0.23 | 0.1 | 0.24 | 0.27 | 0.21 | 0.62 | 0.66 | 0.76 |
| Depreciation | 0.54 | 0.49 | 0.35 | 0.35 | 0.34 | 0.34 | 0.37 | 0.42 | 0.62 | 1.04 | 0.36 | 0.38 | 0.72 |
| PBT | 0.16 | 0.47 | 1.41 | 0.83 | 1.05 | 1.84 | 4.03 | 3.68 | 2.73 | 3.18 | 3.58 | 4.92 | 5.05 |
| Tax % | 0% | 10.64% | 0.71% | 3.61% | 2.86% | 11.41% | 16.38% | 33.97% | 22.71% | 45.28% | 18.99% | 30.89% | — |
| Net Profit | 0.16 | 0.43 | 1.4 | 0.8 | 1.03 | 1.64 | 3.37 | 2.43 | 2.12 | 1.74 | 2.9 | 3.4 | 3.5 |
| EPS (₹) | 0.26 | 0.67 | 2.17 | 1.24 | 1.6 | 2.55 | 5.24 | 3.78 | 3.29 | 2.7 | 4.51 | 5.28 | 5.44 |
| Div. Payout % | 0% | 0% | 0% | 0% | 62.52% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.1 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 |
| Reserves | −0.96 | −0.88 | 0.53 | 1.33 | 2.36 | 3.35 | 6.73 | 9.16 | 11.28 | 13.02 | 15.92 | 19.32 |
| Borrowings | 0.09 | 0.08 | 1.91 | 1.77 | 0.16 | 1.12 | 0.93 | 0.04 | 0.02 | 1.24 | 7.41 | 7.79 |
| Other Liabilities | 0.77 | 0.98 | 2.63 | 1.56 | 1.84 | 2.23 | 3.13 | 3.69 | 3.96 | 4.18 | 6.56 | 7.38 |
| Total Liabilities | 6 | 6.62 | 11.51 | 11.1 | 10.8 | 13.14 | 17.23 | 19.33 | 21.7 | 24.88 | 36.33 | 40.93 |
| Fixed Assets | 3.66 | 3.31 | 3.53 | 3.58 | 3.57 | 3.31 | 3.88 | 5 | 6.56 | 5.52 | 3.93 | 4.16 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0.34 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2.34 | 3.31 | 7.98 | 7.52 | 7.23 | 9.83 | 13.01 | 14.33 | 15.14 | 19.36 | 32.4 | 36.77 |
| Total Assets | 6 | 6.62 | 11.51 | 11.1 | 10.8 | 13.14 | 17.23 | 19.33 | 21.7 | 24.88 | 36.33 | 40.93 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.38 | 0.38 | −0.69 | 0.11 | 2.64 | −0.36 | 4.46 | −0.7 | 2.51 | 2.69 | 0.07 | −2.49 |
| Investing | −0.4 | −0.16 | −1.95 | 0.14 | −0.31 | −0.71 | −2.09 | 0.07 | 0.06 | 0.29 | −5.33 | −2.36 |
| Financing | 0.11 | 0.01 | 2.06 | −0.42 | −1.6 | 0.32 | 0.32 | −1.2 | −0.53 | 1.19 | 5.4 | −0.17 |
| Net Cash Flow | 0.08 | 0.23 | −0.58 | −0.18 | 0.74 | −0.74 | 2.69 | −1.83 | 2.04 | 4.18 | 0.13 | −5.01 |
| Free Cash Flow | −0.02 | 0.24 | −1.26 | −0.29 | 2.31 | −0.44 | 3.2 | −1.9 | 2.59 | 2.69 | −0.02 | −3.1 |
| CFO/OP | 54 | 40 | −38 | 8 | 166 | −15 | 107 | −18 | 70 | 60 | 2 | −42 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12.84 | 27.72 | 101 | 139 | 94.88 | 182 | 87.88 | 131 | 137 | 100 | 99.46 | 92.68 |
| Inventory Days | 218 | 143 | 116 | 203 | 149 | 92.38 | 64.09 | 107 | 142 | 93.59 | 66.2 | 55.94 |
| Days Payable | 108 | 81.7 | 84.18 | 36.13 | 46.29 | 58.58 | 22.1 | 57.67 | 78.93 | 60.94 | 35.55 | 35.9 |
| Cash Conversion Cycle | 123 | 89.26 | 132 | 306 | 198 | 216 | 130 | 180 | 199 | 133 | 130 | 113 |
| Working Capital Days | 57.48 | 53.1 | 74.88 | 125 | 113 | 156 | 68.66 | 163 | 157 | 98.27 | 54.36 | 77.53 |
| ROCE % | 3.31% | 8.83% | 20.39% | 11.62% | 13.51% | 20.84% | 33.11% | 26.36% | 17.97% | 17.9% | 16.64% | 17.62% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Source Natural Foods & Herbal Supplements insights
60 extracted metrics across FY11–FY27.
Documents
- General announcements 14 Oct 2026
- General announcements 1 Oct 2026
Frequently Asked Questions about Source Natural Foods & Herbal Supplements
What does Source Natural Foods & Herbal Supplements Ltd do?
Incorporated in 1998, Source Natural Foods and Herbal Supplements Ltd deals in ayurvedic products and green energy segment.
Where is Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) listed?
Source Natural Foods & Herbal Supplements Ltd trades under code 531398 on the BSE.
Which sector does Source Natural Foods & Herbal Supplements Ltd belong to?
Source Natural Foods & Herbal Supplements Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd trades at a PE ratio of 20.18 as of 4 Nov 2026, on earnings per share of ₹5.44, against a book value of ₹11.77 per share.
What is the 52-week high and low of Source Natural Foods & Herbal Supplements Ltd?
Over the last 52 weeks Source Natural Foods & Herbal Supplements Ltd has traded between ₹96.55 and ₹155.9 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd reported a return on equity of 14.10%. Its debt-to-equity ratio is 0.30.
Company Information
Incorporated in 1998, Source Natural Foods and Herbal Supplements Ltd deals in ayurvedic products and green energy segment.
Website source-natural.com
Face Value ₹10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531398.md for Source Natural Foods & Herbal Supplements Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.